Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
HumanPheno	Infertility	SPAG1 DNAAF4 CFAP44 WDPCP MAP3K1 DNAH1	1.86e-05	314	11	6	HP:0000789
HumanPheno	Male infertility	SPAG1 DNAAF4 CFAP44 MAP3K1 DNAH1	4.18e-05	209	11	5	HP:0003251
HumanPheno	Decreased fertility in females	SPAG1 DNAAF4 MAP3K1 DNAH1	4.85e-05	104	11	4	HP:0000868
HumanPheno	Decreased fertility	SPAG1 DNAAF4 CFAP44 WDPCP MAP3K1 DNAH1	5.55e-05	380	11	6	HP:0000144
HumanPheno	Rhinitis	SPAG1 DNAAF4 WDPCP DNAH1	6.72e-05	113	11	4	HP:0012384
HumanPheno	Decreased fertility in males	SPAG1 DNAAF4 CFAP44 MAP3K1 DNAH1	7.52e-05	236	11	5	HP:0012041
HumanPheno	Peribronchovascular interstitial thickening	SPAG1 DNAAF4 DNAH1	1.31e-04	49	11	3	HP:0025177
HumanPheno	Pulmonary situs ambiguus	SPAG1 DNAAF4 DNAH1	1.31e-04	49	11	3	HP:0011617
HumanPheno	Abnormal pulmonary situs morphology	SPAG1 DNAAF4 DNAH1	1.31e-04	49	11	3	HP:0011615
HumanPheno	Lithoptysis	SPAG1 DNAAF4 DNAH1	1.31e-04	49	11	3	HP:0032543
HumanPheno	Ectopic pregnancy	SPAG1 DNAAF4 DNAH1	1.31e-04	49	11	3	HP:0031456
HumanPheno	Atrial situs ambiguous	SPAG1 DNAAF4 DNAH1	1.39e-04	50	11	3	HP:0011539
HumanPheno	Abnormal inferior vena cava morphology	SPAG1 DNAAF4 DNAH1	1.65e-04	53	11	3	HP:0025576
HumanPheno	Abnormal atrial arrangement	SPAG1 DNAAF4 DNAH1	1.75e-04	54	11	3	HP:0011535
HumanPheno	Nasal congestion	SPAG1 DNAAF4 DNAH1	2.40e-04	60	11	3	HP:0001742
HumanPheno	Recurrent mycobacterial infections	SPAG1 DNAAF4 DNAH1	2.64e-04	62	11	3	HP:0011274
HumanPheno	Wheezing	SPAG1 DNAAF4 DNAH1	2.91e-04	64	11	3	HP:0030828
HumanPheno	Polysplenia	SPAG1 DNAAF4 DNAH1	3.18e-04	66	11	3	HP:0001748
HumanPheno	Recurrent upper and lower respiratory tract infections	SPAG1 DNAAF4 DNAH1	3.48e-04	68	11	3	HP:0002873
HumanPheno	Recurrent sinopulmonary infections	SPAG1 DNAAF4 DNAH1	3.48e-04	68	11	3	HP:0005425
HumanPheno	Productive cough	SPAG1 DNAAF4 DNAH1	3.48e-04	68	11	3	HP:0031245
HumanPheno	Chronic sinusitis	SPAG1 DNAAF4 DNAH1	3.63e-04	69	11	3	HP:0011109
HumanPheno	Chronic rhinitis	SPAG1 DNAAF4 DNAH1	4.29e-04	73	11	3	HP:0002257
HumanPheno	Nasal polyposis	SPAG1 DNAAF4 DNAH1	4.47e-04	74	11	3	HP:0100582
HumanPheno	Atelectasis	SPAG1 DNAAF4 DNAH1	5.62e-04	80	11	3	HP:0100750
HumanPheno	Abnormal nasal mucosa morphology	SPAG1 DNAAF4 DNAH1	5.62e-04	80	11	3	HP:0000433
HumanPheno	Otitis media	SETD2 SPAG1 DNAAF4 WDPCP DNAH1	5.77e-04	363	11	5	HP:0000388
HumanPheno	Persistent left superior vena cava	SPAG1 DNAAF4 DNAH1	6.26e-04	83	11	3	HP:0005301
HumanPheno	Anomalous pulmonary venous return	SPAG1 DNAAF4 DNAH1	6.26e-04	83	11	3	HP:0010772
HumanPheno	Female infertility	SPAG1 DNAAF4 DNAH1	6.49e-04	84	11	3	HP:0008222
HumanPheno	Abnormal superior vena cava morphology	SPAG1 DNAAF4 DNAH1	6.72e-04	85	11	3	HP:0025575
HumanPheno	Transposition of the great arteries	SPAG1 DNAAF4 DNAH1	6.72e-04	85	11	3	HP:0001669
HumanPheno	Abnormal vena cava morphology	SPAG1 DNAAF4 DNAH1	7.44e-04	88	11	3	HP:0030971
HumanPheno	Abnormal vena cava morphology	SPAG1 DNAAF4 DNAH1	7.69e-04	89	11	3	HP:0005345
HumanPheno	Abnormal pulmonary vein morphology	SPAG1 DNAAF4 DNAH1	7.69e-04	89	11	3	HP:0030968
HumanPheno	Abnormality of the pulmonary veins	SPAG1 DNAAF4 DNAH1	7.69e-04	89	11	3	HP:0011718
HumanPheno	Abnormal middle ear morphology	SETD2 SPAG1 DNAAF4 WDPCP DNAH1	8.04e-04	390	11	5	HP:0008609
HumanPheno	Asplenia	SPAG1 DNAAF4 DNAH1	8.20e-04	91	11	3	HP:0001746
HumanPheno	Double outlet right ventricle	SPAG1 DNAAF4 DNAH1	9.02e-04	94	11	3	HP:0001719
HumanPheno	Congenital malformation of the right heart	SPAG1 DNAAF4 DNAH1	9.59e-04	96	11	3	HP:0011723
HumanPheno	Recurrent otitis media	SETD2 SPAG1 DNAAF4 DNAH1	9.89e-04	227	11	4	HP:0000403
HumanPheno	Aplasia/Hypoplasia of the spleen	SPAG1 DNAAF4 DNAH1	1.02e-03	98	11	3	HP:0010451
HumanPheno	Supernumerary spleens	SPAG1 DNAAF4 DNAH1	1.11e-03	101	11	3	HP:0009799
HumanPheno	Polycystic ovaries	SETD2 WDPCP MAP3K1	1.28e-03	106	11	3	HP:0000147
HumanPheno	Chronic bronchitis	SPAG1 DNAAF4	1.44e-03	27	11	2	HP:0004469
HumanPheno	Absent sperm flagella	CFAP44 DNAH1	1.55e-03	28	11	2	HP:0032558
HumanPheno	Abnormal sperm motility	SPAG1 DNAAF4 DNAH1	1.62e-03	115	11	3	HP:0012206
HumanPheno	Abnormal sperm physiology	SPAG1 DNAAF4 DNAH1	1.62e-03	115	11	3	HP:0034809
HumanPheno	Ovarian cystic abnormality	SETD2 WDPCP MAP3K1	1.79e-03	119	11	3	HP:0000146
HumanPheno	Ovarian cyst	SETD2 WDPCP MAP3K1	1.79e-03	119	11	3	HP:0000138
HumanPheno	Ciliary dyskinesia	SPAG1 DNAAF4	2.03e-03	32	11	2	HP:0012265
HumanPheno	Coiled sperm flagella	CFAP44 DNAH1	2.03e-03	32	11	2	HP:0032560
HumanPheno	Short sperm flagella	CFAP44 DNAH1	2.16e-03	33	11	2	HP:0032559
HumanPheno	Abnormal ciliary motility	SPAG1 DNAAF4	2.29e-03	34	11	2	HP:0012262
HumanPheno	Abnormal breath sound	SPAG1 DNAAF4 DNAH1	2.46e-03	133	11	3	HP:0030829
HumanPheno	Abnormal respiratory motile cilium physiology	SPAG1 DNAAF4	2.57e-03	36	11	2	HP:0012261
HumanPheno	Abnormal sputum	SPAG1 DNAAF4 DNAH1	2.62e-03	136	11	3	HP:0032016
HumanPheno	Airway obstruction	SPAG1 DNAAF4 DNAH1	2.68e-03	137	11	3	HP:0006536
HumanPheno	Abdominal situs inversus	SPAG1 DNAAF4 DNAH1	2.97e-03	142	11	3	HP:0003363
HumanPheno	Abnormal spatial orientation of the cardiac segments	SPAG1 DNAAF4 DNAH1	2.97e-03	142	11	3	HP:0011534
HumanPheno	Abnormality of abdominal situs	SPAG1 DNAAF4 DNAH1	2.97e-03	142	11	3	HP:0011620
HumanPheno	Situs inversus totalis	SPAG1 DNAAF4 DNAH1	2.97e-03	142	11	3	HP:0001696
HumanPheno	Heterotaxy	SPAG1 DNAAF4 DNAH1	3.15e-03	145	11	3	HP:0030853
HumanPheno	Clubbing	SPAG1 DNAAF4 DNAH1	3.60e-03	152	11	3	HP:0001217
HumanPheno	Abnormal sperm tail morphology	CFAP44 DNAH1	3.65e-03	43	11	2	HP:0012868
HumanPheno	Neonatal respiratory distress	SPAG1 DNAAF4 DNAH1	3.74e-03	154	11	3	HP:0002643
HumanPheno	Chronic otitis media	SPAG1 DNAAF4 DNAH1	3.88e-03	156	11	3	HP:0000389
HumanPheno	Abnormal pulmonary thoracic imaging finding	SPAG1 DNAAF4 DNAH1	3.95e-03	157	11	3	HP:0031983
HumanPheno	Intestinal malrotation	SPAG1 DNAAF4 DNAH1	3.95e-03	157	11	3	HP:0002566
HumanPheno	Dextrocardia	SPAG1 DNAAF4 DNAH1	4.09e-03	159	11	3	HP:0001651
HumanPheno	Abnormal anatomic location of the heart	SPAG1 DNAAF4 DNAH1	4.17e-03	160	11	3	HP:0004307
HumanPheno	Cough	SPAG1 DNAAF4 DNAH1	4.17e-03	160	11	3	HP:0012735
HumanPheno	Abnormal pulmonary interstitial morphology	SPAG1 DNAAF4 DNAH1	4.24e-03	161	11	3	HP:0006530
HumanPheno	Aplasia/Hypoplasia of the vagina	WDPCP MAP3K1	4.35e-03	47	11	2	HP:0011026
MousePheno	decreased respiratory mucosa goblet cell number	SERPINB3 SERPINB4	8.35e-05	5	41	2	MP:0010862
MousePheno	enlarged thymus cortex	CTSV RYR2	8.35e-05	5	41	2	MP:0013593
Domain	Arp3_met	ACTR3C ACTR3B	1.86e-05	3	47	2	IPR015623
Domain	FHA	PPP1R8 MKI67 KIF13A	4.68e-05	28	47	3	SM00240
Domain	FHA_DOMAIN	PPP1R8 MKI67 KIF13A	6.39e-05	31	47	3	PS50006
Domain	FHA	PPP1R8 MKI67 KIF13A	6.39e-05	31	47	3	PF00498
Domain	FHA_dom	PPP1R8 MKI67 KIF13A	1.01e-04	36	47	3	IPR000253
Domain	-	PPP1R8 MKI67 KIF13A	1.01e-04	36	47	3	2.60.200.20
Domain	RNase_Zc3h12a	ZC3H12B ZC3H12C	1.29e-04	7	47	2	PF11977
Domain	RNase_Zc3h12_NYN	ZC3H12B ZC3H12C	1.29e-04	7	47	2	IPR021869
Domain	SMAD_FHA_domain	PPP1R8 MKI67 KIF13A	3.03e-04	52	47	3	IPR008984
Domain	ACTINS_ACT_LIKE	ACTR3C ACTR3B	1.03e-03	19	47	2	PS01132
Domain	TPR_1	SPAG1 DNAAF4 UTY	1.51e-03	90	47	3	PF00515
Domain	TPR_1	SPAG1 DNAAF4 UTY	1.51e-03	90	47	3	IPR001440
Domain	Actin	ACTR3C ACTR3B	2.75e-03	31	47	2	IPR004000
Domain	Actin	ACTR3C ACTR3B	2.75e-03	31	47	2	PF00022
Domain	ACTIN	ACTR3C ACTR3B	2.75e-03	31	47	2	SM00268
Domain	Serpin_CS	SERPINB3 SERPINB4	2.93e-03	32	47	2	IPR023795
Domain	Serpin_dom	SERPINB3 SERPINB4	3.70e-03	36	47	2	IPR023796
Domain	SERPIN	SERPINB3 SERPINB4	3.90e-03	37	47	2	SM00093
Domain	SERPIN	SERPINB3 SERPINB4	3.90e-03	37	47	2	PS00284
Domain	Serpin	SERPINB3 SERPINB4	4.11e-03	38	47	2	PF00079
Domain	TPR	SPAG1 DNAAF4 UTY	4.18e-03	129	47	3	SM00028
Domain	Serpin_fam	SERPINB3 SERPINB4	4.33e-03	39	47	2	IPR000215
Domain	TPR_repeat	SPAG1 DNAAF4 UTY	4.55e-03	133	47	3	IPR019734
Domain	TPR-contain_dom	SPAG1 DNAAF4 UTY	6.36e-03	150	47	3	IPR013026
Domain	WW_DOMAIN_2	SETD2 IQGAP2	7.31e-03	51	47	2	PS50020
Domain	WW_DOMAIN_1	SETD2 IQGAP2	7.31e-03	51	47	2	PS01159
Domain	WW_dom	SETD2 IQGAP2	7.59e-03	52	47	2	IPR001202
Domain	TPR_8	SPAG1 UTY	7.87e-03	53	47	2	PF13181
Domain	TPR_REGION	SPAG1 DNAAF4 UTY	8.26e-03	165	47	3	PS50293
Domain	TPR	SPAG1 DNAAF4 UTY	8.26e-03	165	47	3	PS50005
Domain	Znf_CCCH	ZC3H12B ZC3H12C	9.37e-03	58	47	2	IPR000571
Domain	ZF_C3H1	ZC3H12B ZC3H12C	9.37e-03	58	47	2	PS50103
Pubmed	The amplified mouse squamous cell carcinoma antigen gene locus contains a serpin (Serpinb3b) that inhibits both papain-like cysteine and trypsin-like serine proteinases.	SERPINB3 SERPINB4	1.94e-06	2	49	2	15203214
Pubmed	Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure.	SERPINB3 SERPINB4	1.94e-06	2	49	2	23354406
Pubmed	Serpin B4 isoform overexpression is associated with aberrant epithelial proliferation and lung cancer in idiopathic pulmonary fibrosis.	SERPINB3 SERPINB4	1.94e-06	2	49	2	22406480
Pubmed	Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.	SERPINB3 SERPINB4	1.94e-06	2	49	2	27668655
Pubmed	Characterization of novel squamous cell carcinoma antigen-related molecules in mice.	SERPINB3 SERPINB4	1.94e-06	2	49	2	15504361
Pubmed	SCCA2-like serpins mediate genetic predisposition to skin tumors.	SERPINB3 SERPINB4	1.94e-06	2	49	2	12702576
Pubmed	Serpinb3 is overexpressed in the liver in presence of iron overload.	SERPINB3 SERPINB4	1.94e-06	2	49	2	28935635
Pubmed	Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins.	SERPINB3 SERPINB4	1.94e-06	2	49	2	35022507
Pubmed	Isolation of a novel actin-related gene expressed in low-metastatic PC-14 human lung adenocarcinoma.	ACTR3C ACTR3B	1.94e-06	2	49	2	11162478
Pubmed	Overexpression of SERPIN B3 promotes epithelial proliferation and lung fibrosis in mice.	SERPINB3 SERPINB4	1.94e-06	2	49	2	21403642
Pubmed	SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.	SERPINB3 SERPINB4	1.94e-06	2	49	2	25111616
Pubmed	Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter.	SERPINB3 SERPINB4	1.94e-06	2	49	2	11267667
Pubmed	Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours.	SERPINB3 SERPINB4	1.94e-06	2	49	2	29491058
Pubmed	Squamous cell carcinoma antigen production in nasal inverted papilloma.	SERPINB3 SERPINB4	1.94e-06	2	49	2	23168150
Pubmed	The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases.	SERPINB3 SERPINB4	1.94e-06	2	49	2	11863458
Pubmed	IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.	SERPINB3 SERPINB4	1.94e-06	2	49	2	22808225
Pubmed	Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.	SERPINB3 SERPINB4	1.94e-06	2	49	2	14970861
Pubmed	Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas.	SERPINB3 SERPINB4	1.94e-06	2	49	2	10653592
Pubmed	Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer.	SERPINB3 SERPINB4	1.94e-06	2	49	2	29112685
Pubmed	Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells.	SERPINB3 SERPINB4	1.94e-06	2	49	2	10956412
Pubmed	Expression of the Arp11 gene suppresses the tumorigenicity of PC-14 human lung adenocarcinoma cells.	ACTR3C ACTR3B	1.94e-06	2	49	2	14651955
Pubmed	Tumor-related protein, the squamous cell carcinoma antigen binds to the intracellular protein carbonyl reductase.	SERPINB3 SERPINB4	1.94e-06	2	49	2	20428762
Pubmed	SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease.	SERPINB3 SERPINB4	1.94e-06	2	49	2	35874657
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	PPP1R8 MCMBP FRMD6 SERPINB3 SERPINB4 MKI67	2.19e-06	270	49	6	24366813
Pubmed	Serpin B3/B4, activated by STAT3, promote survival of squamous carcinoma cells.	SERPINB3 SERPINB4	5.83e-06	3	49	2	19070595
Pubmed	A murine ortholog of the human serpin SCCA2 maps to chromosome 1 and inhibits chymotrypsin-like serine proteinases.	SERPINB3 SERPINB4	5.83e-06	3	49	2	9828132
Pubmed	Anti-apoptotic effects of SERPIN B3 and B4 via STAT6 activation in macrophages after infection with Toxoplasma gondii.	SERPINB3 SERPINB4	5.83e-06	3	49	2	22451727
Pubmed	A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene.	SERPINB3 SERPINB4	5.83e-06	3	49	2	7724531
Pubmed	Differentially expressed proteins in human breast cancer cells sensitive and resistant to paclitaxel.	SERPINB3 SERPINB4	5.83e-06	3	49	2	24898082
Pubmed	A nonredundant role for mouse Serpinb3a in the induction of mucus production in asthma.	SERPINB3 SERPINB4	5.83e-06	3	49	2	21126757
Pubmed	Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).	SERPINB3 SERPINB4	5.83e-06	3	49	2	24635038
Pubmed	Heparin enhances serpin inhibition of the cysteine protease cathepsin L.	SERPINB3 SERPINB4	5.83e-06	3	49	2	19959474
Pubmed	Uteroglobin suppresses SCCA gene expression associated with allergic asthma.	SERPINB3 SERPINB4	5.83e-06	3	49	2	15677460
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	MCMBP KLF10 BCLAF1 EIF4G1 MKI67 ELF1 KIF13A	6.45e-06	503	49	7	16964243
Pubmed	Out-of-frame start codons prevent translation of truncated nucleo-cytosolic cathepsin L in vivo.	MKI67 CTSV	1.16e-05	4	49	2	25222295
Pubmed	Serpin squamous cell carcinoma antigen inhibits UV-induced apoptosis via suppression of c-JUN NH2-terminal kinase.	SERPINB3 SERPINB4	1.16e-05	4	49	2	16549498
Pubmed	A novel CCCH-zinc finger protein family regulates proinflammatory activation of macrophages.	ZC3H12B ZC3H12C	1.16e-05	4	49	2	18178554
Pubmed	Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1.	SERPINB3 SERPINB4	1.16e-05	4	49	2	12949073
Pubmed	Squamous cell carcinoma antigen 1 promotes caspase-8-mediated apoptosis in response to endoplasmic reticulum stress while inhibiting necrosis induced by lysosomal injury.	SERPINB3 SERPINB4	1.16e-05	4	49	2	21576355
Pubmed	Primary Ciliary Dyskinesia	SPAG1 DNAAF4 DNAH1	1.27e-05	32	49	3	20301301
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	MCMBP SERPINB3 EIF4G1 MKI67 ACTR3B ME2 MAP3K1 DNPEP	2.18e-05	844	49	8	25963833
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	PPP1R8 UBTD1 BCLAF1 EIF4G1 MKI67 ACTR3B TFAM	3.69e-05	660	49	7	32780723
Pubmed	Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.	SERPINB3 SERPINB4 BCLAF1 MKI67 CKAP5	4.06e-05	272	49	5	31010829
Pubmed	Mitochondrial Cardiomyopathy Caused by Elevated Reactive Oxygen Species and Impaired Cardiomyocyte Proliferation.	MKI67 TFAM	4.07e-05	7	49	2	29021295
Pubmed	Cathepsin proteases have distinct roles in trophoblast function and vascular remodelling.	MKI67 CTSV	5.42e-05	8	49	2	18776147
Pubmed	UTX deficiency in neural stem/progenitor cells results in impaired neural development, fetal ventriculomegaly, and postnatal death.	MKI67 UTY	5.42e-05	8	49	2	36412518
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	PPP1R8 FRMD6 IQGAP2 SERPINB3 SERPINB4 BCLAF1 EIF4G1 ACTR3B DNPEP	6.72e-05	1284	49	9	17353931
Pubmed	Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development.	SEMA3D MKI67	6.96e-05	9	49	2	27160901
Pubmed	Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.	ABI3BP RYR2	6.96e-05	9	49	2	23829686
Pubmed	Deletion of Tfam in Prx1-Cre expressing limb mesenchyme results in spontaneous bone fractures.	MKI67 TFAM	8.69e-05	10	49	2	35947192
Pubmed	The mitochondrial electron transport chain is dispensable for proliferation and differentiation of epidermal progenitor cells.	MKI67 TFAM	8.69e-05	10	49	2	21780252
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT1 FRMD6 IQGAP2 BCLAF1 MKI67 DCLRE1A RYR2	1.03e-04	777	49	7	35844135
Pubmed	Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus.	SERPINB3 SERPINB4	1.06e-04	11	49	2	15203215
Pubmed	Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.	ZC3H12C RYR2	1.06e-04	11	49	2	17903301
Pubmed	Hepatocyte growth factor-regulated tyrosine kinase substrate is essential for endothelial cell polarity and cerebrovascular stability.	MKI67 KIF13A	1.27e-04	12	49	2	32044971
Pubmed	RBPMS is an RNA-binding protein that mediates cardiomyocyte binucleation and cardiovascular development.	MKI67 RYR2	1.27e-04	12	49	2	35472321
Pubmed	IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade.	IQGAP2 MKI67	1.27e-04	12	49	2	18604197
Pubmed	UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program.	MKI67 UTY	1.50e-04	13	49	2	22192413
Pubmed	Comparison of human chromosome 6p25 with mouse chromosome 13 reveals a greatly expanded ov-serpin gene repertoire in the mouse.	SERPINB3 SERPINB4	1.50e-04	13	49	2	11863365
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	NIBAN1 BCLAF1 EIF4G1 CKAP5 ELF1	1.72e-04	370	49	5	22922362
Pubmed	MED12 regulates a transcriptional network of calcium-handling genes in the heart.	MKI67 RYR2	1.75e-04	14	49	2	28724790
Pubmed	Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter.	GCNT1 CTSV	1.75e-04	14	49	2	2034277
Pubmed	A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening.	KLF10 ELF1	1.75e-04	14	49	2	10976766
Pubmed	Astrocyte-intrinsic and -extrinsic Fat1 activities regulate astrocyte development and angiogenesis in the retina.	FAT1 MKI67	1.75e-04	14	49	2	35050341
Pubmed	Spatiotemporal role of SETD2-H3K36me3 in murine pancreatic organogenesis.	SETD2 MKI67	1.75e-04	14	49	2	38265933
Pubmed	The APMAP interactome reveals new modulators of APP processing and beta-amyloid production that are altered in Alzheimer's disease.	SERPINB3 SERPINB4	2.02e-04	15	49	2	30704515
Pubmed	KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis.	MKI67 UTY	2.30e-04	16	49	2	35212626
Pubmed	Deficiency in the secreted protein Semaphorin3d causes abnormal parathyroid development in mice.	SEMA3D MKI67	2.30e-04	16	49	2	30979723
Pubmed	LINC00240 in the 6p22.1 risk locus promotes gastric cancer progression through USP10-mediated DDX21 stabilization.	MKI67 CKAP5	2.61e-04	17	49	2	37072811
Pubmed	GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system.	IQGAP2 BCLAF1 EIF4G1 CKAP5	2.69e-04	221	49	4	29991511
Pubmed	Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development.	FAT1 MKI67	2.93e-04	18	49	2	26209645
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	SERPINB3 SERPINB4 BCLAF1 MKI67 DCLRE1A TFAM	2.99e-04	652	49	6	31180492
Pubmed	Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.	SERPINB4 BCLAF1 EIF4G1 MKI67	3.97e-04	245	49	4	21182205
Pubmed	Wdpcp promotes epicardial EMT and epicardium-derived cell migration to facilitate coronary artery remodeling.	MKI67 WDPCP	4.01e-04	21	49	2	29487191
Pubmed	Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SETD2 ZC3H12C ACAP3	4.09e-04	102	49	3	11214970
Pubmed	A genomic analysis of rat proteases and protease inhibitors.	SERPINB3 SERPINB4	4.83e-04	23	49	2	15060002
Pubmed	Microarray meta-analysis identifies evolutionarily conserved BMP signaling targets in developing long bones.	KLF10 DNPEP	5.26e-04	24	49	2	24583261
Pubmed	Loss of connectin novex-3 leads to heart dysfunction associated with impaired cardiomyocyte proliferation and abnormal nuclear mechanics.	MKI67 RYR2	5.71e-04	25	49	2	38877142
Pubmed	Tshz1 Regulates Pancreatic β-Cell Maturation.	MKI67 TFAM	5.71e-04	25	49	2	25918232
Pubmed	Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt.	MCMBP BCLAF1 EIF4G1 CKAP5	5.80e-04	271	49	4	25737280
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	SPAG1 MCMBP SERPINB3 BCLAF1 EIF4G1 CKAP5 ME2 TFAM	5.99e-04	1367	49	8	32687490
Pubmed	TFAM is required for maturation of the fetal and adult intestinal epithelium.	MKI67 TFAM	6.18e-04	26	49	2	29684311
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	IQGAP2 EIF4G1 MKI67 CKAP5 TFAM MAP3K1	6.66e-04	759	49	6	35915203
Pubmed	TRAIP regulates replication fork recovery and progression via PCNA.	MCMBP MKI67	6.67e-04	27	49	2	27462463
Pubmed	Blood pressure is regulated by an alpha1D-adrenergic receptor/dystrophin signalosome.	CKAP5 RYR2	6.67e-04	27	49	2	18468998
Pubmed	Protein translation rate determines neocortical neuron fate.	EIF4G1 MKI67	6.67e-04	27	49	2	38849354
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	BCLAF1 EIF4G1 RYR2	7.06e-04	123	49	3	26912792
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SETD2 BCLAF1 EIF4G1 MKI67 CKAP5 ELF1	7.38e-04	774	49	6	15302935
Pubmed	Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons.	FRMD6 MKI67	7.71e-04	29	49	2	31491374
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MCMBP SERPINB3 BCLAF1 EIF4G1 MKI67 CKAP5 ME2 DNPEP	7.86e-04	1425	49	8	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	IQGAP2 ACTR3C BCLAF1 EIF4G1 CKAP5 ACTR3B TFAM DNPEP	8.08e-04	1431	49	8	37142655
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SPAG1 ABI3BP IQGAP2 BCLAF1 TRO EIF4G1 TFAM RYR2	8.49e-04	1442	49	8	35575683
Pubmed	Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling.	SERPINB3 SERPINB4	8.81e-04	31	49	2	36971701
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	NIBAN1 UBTD1 TRIM61 ACTR3B WDPCP RYR2	9.58e-04	814	49	6	23251661
Pubmed	Hypertrophic Cardiomyopathy Overview	KLF10 RYR2	1.06e-03	34	49	2	20301725
Pubmed	Insulin and IGF1 receptors are essential for XX and XY gonadal differentiation and adrenal development in mice.	MKI67 MAP3K1	1.06e-03	34	49	2	23300479
Pubmed	SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.	SERPINB3 BCLAF1 EIF4G1 CFAP44 TFAM	1.11e-03	558	49	5	27591049
Pubmed	Inflammation-like changes in the urothelium of Lifr-deficient mice and LIFR-haploinsufficient humans with urinary tract anomalies.	MKI67 GCNT1	1.12e-03	35	49	2	32179912
Pubmed	The P-body component USP52/PAN2 is a novel regulator of HIF1A mRNA stability.	UBTD1 BCLAF1 ACTR3B TFAM	1.18e-03	328	49	4	23398456
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	BCLAF1 EIF4G1 MKI67 CKAP5	1.20e-03	330	49	4	32529326
Cytoband	18q21.3	SERPINB3 SERPINB4	6.10e-05	11	49	2	18q21.3
Cytoband	8q22.2	SPAG1 KLF10	2.78e-04	23	49	2	8q22.2
Cytoband	3p21.1	ITIH1 DNAH1	9.35e-04	42	49	2	3p21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr18q21	SERPINB3 SERPINB4 ME2	1.39e-03	205	49	3	chr18q21
Cytoband	7q36.1	ACTR3C ACTR3B	2.87e-03	74	49	2	7q36.1
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	SETD2 ITIH1 DNAH1	4.71e-03	316	49	3	chr3p21
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SPAG1 DNAAF4 UTY	1.19e-03	115	33	3	769
GeneFamily	Zinc fingers CCCH-type	ZC3H12B ZC3H12C	1.85e-03	35	33	2	73
GeneFamily	Serpin peptidase inhibitors	SERPINB3 SERPINB4	2.07e-03	37	33	2	739
Coexpression	HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL	SEMA3D NIBAN1 UBTD1 ABI3BP FRMD6 GCNT1 CCDC102B MAP3K1	5.06e-07	382	49	8	M45756
Coexpression	MCCLUNG_COCAIN_REWARD_4WK	KLF10 SERPINB3 SERPINB4 DCLRE1A	1.25e-05	76	49	4	MM682
Coexpression	HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL	NIBAN1 FRMD6 IQGAP2 MKI67 DCLRE1A TRIM68 GCNT1 CCDC102B TMEM19 CTSV	2.09e-05	1054	49	10	M45798
Coexpression	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	MCMBP SERPINB4 DCLRE1A CCDC102B ME2	3.24e-05	196	49	5	M5313
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D ABI3BP FRMD6 IPCEF1 CCDC102B	1.69e-06	182	49	5	53c267ee327e116dbd89d5927ed3bdf78d25ee62
ToppCell	Basal_cells-IPF_02\|World / lung cells shred on cell class, cell subclass, sample id	FAT1 FRMD6 SERPINB3 SERPINB4 TRO	2.14e-06	191	49	5	a98915bad9a4a61dd4cbca798914849b805f4a19
ToppCell	Control_saline-Epithelial_airway-airway_epithelial\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAAF4 SERPINB4 CFAP44 CTSV DNAH1	2.56e-06	198	49	5	e7aa42e5fbd42c68f50cda4a8f3aa464c862c007
ToppCell	Control_saline-Epithelial_airway\|Control_saline / Treatment groups by lineage, cell group, cell type	DNAAF4 SERPINB4 CFAP44 CTSV DNAH1	2.56e-06	198	49	5	e6863238e022ecfb6a8e3f4b7661b376e92c5d8f
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SEMA3D FAT1 ABI3BP FRMD6 RYR2	2.69e-06	200	49	5	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	SEMA3D FAT1 ABI3BP FRMD6 RYR2	2.69e-06	200	49	5	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	SEMA3D FAT1 ABI3BP FRMD6 RYR2	2.69e-06	200	49	5	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3\|Control_saline / Treatment groups by lineage, cell group, cell type	PRSS35 NIBAN1 FAT1 CCDC102B RYR2	2.69e-06	200	49	5	b0866b497aa71d06cef25f9a335fa584e95fa7e0
ToppCell	Control_saline-Mesenchymal_myocytic\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT1 ABI3BP FRMD6 CCDC102B RYR2	2.69e-06	200	49	5	5ed4261157cd51109b314818133ac3a0d34ee5fa
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	PRSS35 NIBAN1 FAT1 CCDC102B RYR2	2.69e-06	200	49	5	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	Tracheal-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PRSS35 CCDC102B ITIH1	2.03e-05	48	49	3	0b71435d798c6b25089a16b25d1d535f3c780d30
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PRSS35 KLF10 ABI3BP IPCEF1	2.48e-05	154	49	4	12cbc38bc1f7231c67e1d2d5e86e95bc12e24682
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PRSS35 KLF10 ABI3BP IPCEF1	2.61e-05	156	49	4	fe383ce3a0c37f7343d7026cb51260a04d4c2829
ToppCell	facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETD2 MKI67 ANKRD49 ME2	2.95e-05	161	49	4	a7e74bc80ac11250e353e5614b19c05793fc2e95
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FAT1 FRMD6 ZC3H12C MAP3K1	3.57e-05	169	49	4	2833a8a7094e4d407eb923f2bc59b9b112c6bae4
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IQGAP2 IPCEF1 MKI67 ME2	3.65e-05	170	49	4	da4dde7d0491ccc298cec7474a6a76ff3db36a4c
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	FRMD6 SERPINB3 SERPINB4 TMEM19	3.73e-05	171	49	4	adbcfa4bf6bc1c604535a24435924cdb091e2dd7
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS35 NIBAN1 TP53TG5 CCDC102B	3.82e-05	172	49	4	107417cfab7775bc1f80807115047abfb50b7a7e
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	IQGAP2 IPCEF1 MKI67 ME2	3.82e-05	172	49	4	4bdcf1ae2a1cfba0272c54072e37fb7958904321
ToppCell	droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAG1 IQGAP2 DNAAF4 IPCEF1	4.00e-05	174	49	4	6987fe7959afce347282f632abc16d800ccab7c4
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT1 TP53TG5 CCDC102B RYR2	4.00e-05	174	49	4	015d3742d3d79a57413a333f00ef2d380a9848dd
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FRMD6 SERPINB3 SERPINB4 MKI67	4.09e-05	175	49	4	9142ed8ca2f1c0c518deb21988221406f62fe38c
ToppCell	P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NIBAN1 IQGAP2 MKI67 ME2	4.56e-05	180	49	4	1e819c5c87704ec6535dfeaae56561895e239d07
ToppCell	droplet-Lung-nan-18m-Myeloid-Proliferating_Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MKI67 CKAP5 DCLRE1A ACTR3B	4.56e-05	180	49	4	43fd5c498a87bb078d101298b472656f3294686a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D NIBAN1 ABI3BP FRMD6	4.76e-05	182	49	4	41b070085edba7a58b81c20aa4942d06f745acf8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D NIBAN1 ABI3BP FRMD6	4.76e-05	182	49	4	5e9a67b2de0daa4fdc344b10a857d8a901ad810e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA3D NIBAN1 ABI3BP FRMD6	4.76e-05	182	49	4	b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D ABI3BP FRMD6 IPCEF1	4.86e-05	183	49	4	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MKI67 CKAP5 DCLRE1A ACTR3B	4.86e-05	183	49	4	e91f00b75d43ee6293fdd4a129b789cd95f8d11a
ToppCell	3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D PTCHD3 FRMD6 IPCEF1	4.97e-05	184	49	4	968afa6b5ba84169377a24c150bb68749fa674d9
ToppCell	3'-Broncho-tracheal-Endothelial-Lymphatic_EC\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D PTCHD3 FRMD6 IPCEF1	4.97e-05	184	49	4	15cbddea9efb2346a2028d77edfe9ba32923568f
ToppCell	3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D PTCHD3 FRMD6 IPCEF1	4.97e-05	184	49	4	0087c605c161fd8a39aa394f51994a04e8353bf1
ToppCell	3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D PTCHD3 FRMD6 IPCEF1	4.97e-05	184	49	4	920f95625978132c2b6c76654ef6298244103e2d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	NIBAN1 ABI3BP IPCEF1 RYR2	4.97e-05	184	49	4	d2bf0135eb56bb410997dccea39c5ede88a0617f
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PRSS35 SEMA3D ABI3BP CTSV	5.07e-05	185	49	4	c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NIBAN1 FAT1 CCDC102B RYR2	5.18e-05	186	49	4	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SEMA3D ABI3BP FRMD6 IPCEF1	5.18e-05	186	49	4	40070d9cd20188ba49b32acfca9bc16256b38bf5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT1 ABI3BP IPCEF1 MAP3K1	5.18e-05	186	49	4	5c4ffe4e4d5536ae9f8794277fe032c693e7dd56
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NIBAN1 FAT1 CCDC102B RYR2	5.18e-05	186	49	4	a95744b8649096bd7cfc3591a02841fa411085b3
ToppCell	Control-Fibroblasts-Other_FB\|Control / group, cell type (main and fine annotations)	ABI3BP FRMD6 CCDC102B RYR2	5.29e-05	187	49	4	bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SEMA3D NIBAN1 KIF13A RYR2	5.40e-05	188	49	4	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	PRSS35 FAT1 FRMD6 CCDC102B	5.51e-05	189	49	4	1ff4f8da572bdc6356e9df9f41a7f62c81d4c570
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT1 ABI3BP CCDC102B RYR2	5.51e-05	189	49	4	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NIBAN1 ABI3BP FRMD6 RYR2	5.51e-05	189	49	4	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	IPF-Epithelial-Basal\|IPF / Disease state, Lineage and Cell class	FAT1 FRMD6 SERPINB3 SERPINB4	5.63e-05	190	49	4	ea19e9ce954f2dfde97388db9695325cd92ab88f
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 NIBAN1 FAT1 RYR2	5.63e-05	190	49	4	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ABI3BP FRMD6 CCDC102B RYR2	5.63e-05	190	49	4	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SEMA3D ABI3BP CCDC102B MAP3K1	5.63e-05	190	49	4	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SEMA3D ABI3BP CCDC102B RYR2	5.74e-05	191	49	4	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SEMA3D ABI3BP FRMD6 RYR2	5.74e-05	191	49	4	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD2 SPAG1 BCLAF1 ELF1	5.74e-05	191	49	4	1ecd9849d14d5ebf3daf610e83fb50820cafd3ed
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	NIBAN1 IQGAP2 IPCEF1 MKI67	5.74e-05	191	49	4	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT1 ABI3BP CCDC102B RYR2	5.74e-05	191	49	4	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA3D ABI3BP FRMD6 CCDC102B	5.86e-05	192	49	4	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SEMA3D ABI3BP FRMD6 CCDC102B	5.86e-05	192	49	4	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	IPF-Epithelial-Basal\|World / Disease state, Lineage and Cell class	FAT1 FRMD6 SERPINB3 SERPINB4	5.86e-05	192	49	4	9b91e0b162e6f3ce86dd15cc33c2e745d069581f
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT1 ABI3BP CCDC102B RYR2	5.86e-05	192	49	4	992d08092edbc68c47b945deb8708379738c239a
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SEMA3D ABI3BP CCDC102B MAP3K1	5.86e-05	192	49	4	d43caf42ec744e895137f31ef65a990e250669d2
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	SEMA3D ABI3BP FRMD6 CCDC102B	5.86e-05	192	49	4	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SEMA3D ABI3BP FRMD6 CCDC102B	5.98e-05	193	49	4	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRSS35 NIBAN1 MKI67 CKAP5	5.98e-05	193	49	4	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	ABI3BP FRMD6 CCDC102B RYR2	6.10e-05	194	49	4	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	nucseq-Mesenchymal-Myocytic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FAT1 FRMD6 CCDC102B RYR2	6.10e-05	194	49	4	2d66091097e106c7bee22e5281f50724700bdf8d
ToppCell	distal-2-Endothelial-Lymphatic\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SEMA3D UBTD1 PTCHD3 FRMD6	6.22e-05	195	49	4	8e0f67a67af3bc0b16f48a621f74540f136383b7
ToppCell	Control_saline-Epithelial_airway-airway_epithelial-Ciliated\|Control_saline / Treatment groups by lineage, cell group, cell type	SPAG1 DNAAF4 CFAP44 DNAH1	6.22e-05	195	49	4	60067b5359174f0d1a8b5748bfc0690762e9e740
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRSS35 ABI3BP CCDC102B RYR2	6.35e-05	196	49	4	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	IPF-Stromal-Myofibroblast\|IPF / Disease state, Lineage and Cell class	ABI3BP FRMD6 CCDC102B RYR2	6.35e-05	196	49	4	2d0a48e49b3b37bb66e33e74c52915911e1f8a74
ToppCell	distal-Endothelial-Lymphatic\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SEMA3D UBTD1 PTCHD3 FRMD6	6.35e-05	196	49	4	3e8a20e1d163dcbd3bbd99fe179d54af02298af0
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	ABI3BP FRMD6 CCDC102B RYR2	6.35e-05	196	49	4	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	Basal_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	FAT1 FRMD6 SERPINB3 SERPINB4	6.35e-05	196	49	4	3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT1 SERPINB3 SERPINB4 MKI67	6.47e-05	197	49	4	fb272c9c60ee3d980e528044dc567b4925a23da6
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	ABI3BP FRMD6 CCDC102B RYR2	6.47e-05	197	49	4	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Basal_cells\|World / lung cells shred on cell class, cell subclass, sample id	FAT1 FRMD6 SERPINB3 SERPINB4	6.47e-05	197	49	4	24360b660000bdfb999d58fbf4e29585a97e1785
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	ABI3BP FRMD6 CCDC102B RYR2	6.47e-05	197	49	4	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT1 SERPINB3 SERPINB4 MKI67	6.47e-05	197	49	4	61c0d78b29dc4ad8a84172cbfcdab03f31351d0e
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT1 SERPINB3 SERPINB4 MKI67	6.47e-05	197	49	4	dcabea5c50c133c9a4e294e447462d0393174ea7
ToppCell	distal-Endothelial-Lymphatic-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SEMA3D UBTD1 PTCHD3 FRMD6	6.47e-05	197	49	4	8f2e19409ebe9a490d5a245fa82c765ed6d77c3e
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ABI3BP FRMD6 CCDC102B RYR2	6.60e-05	198	49	4	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Epithelial_cells-Basal_cells\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	FRMD6 SERPINB3 SERPINB4 GCNT1	6.60e-05	198	49	4	4235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT1 SERPINB3 SERPINB4 MKI67	6.60e-05	198	49	4	e06d41a7254a09e037ec404be2d8c352d5cbd7f4
ToppCell	IPF-Stromal\|IPF / Disease state, Lineage and Cell class	ABI3BP FRMD6 CCDC102B RYR2	6.60e-05	198	49	4	ece914c32c9b123b779aa9624b92e6230763a20e
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SEMA3D ABI3BP CCDC102B RYR2	6.60e-05	198	49	4	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT1 ABI3BP FRMD6 IQGAP2	6.73e-05	199	49	4	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial\|6m / Sample Type, Dataset, Time_group, and Cell type.	NIBAN1 ABI3BP FRMD6 CCDC102B	6.86e-05	200	49	4	2cc98abf11f5b58707de45a2282f03d47f00f035
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT1 ABI3BP CCDC102B RYR2	6.86e-05	200	49	4	67dcbd86fbc79fd585d0793f979e4aac100326c9
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	NIBAN1 FAT1 CCDC102B RYR2	6.86e-05	200	49	4	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell\|6m / Sample Type, Dataset, Time_group, and Cell type.	NIBAN1 ABI3BP FRMD6 CCDC102B	6.86e-05	200	49	4	0f7431f670f3a175377cefae3479403a881bb8fb
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_basal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT1 FRMD6 SERPINB3 SERPINB4	6.86e-05	200	49	4	8827653738a931e4a4545e0c7d75be12bed40740
ToppCell	Control_saline-Mesenchymal_myocytic-Pericyte\|Control_saline / Treatment groups by lineage, cell group, cell type	NIBAN1 FAT1 CCDC102B RYR2	6.86e-05	200	49	4	cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAT1 ABI3BP FRMD6 CCDC102B	6.86e-05	200	49	4	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRSS35 NIBAN1 FAT1 CCDC102B	6.86e-05	200	49	4	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SETD2 IQGAP2 BCLAF1 ELF1	6.86e-05	200	49	4	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SERPINB4 CFAP44 CTSV DNAH1	6.86e-05	200	49	4	da12821e8a0657869ca0f75d351cce2d7605a505
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SEMA3D FAT1 ABI3BP FRMD6	6.86e-05	200	49	4	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	NIBAN1 FAT1 CCDC102B RYR2	6.86e-05	200	49	4	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SEMA3D ABI3BP FRMD6 CCDC102B	6.86e-05	200	49	4	74e74123ea7bf38d337a3a0248a6a51437c6ab42
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	FAT1 ABI3BP CCDC102B RYR2	6.86e-05	200	49	4	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	LPS_IL1RA_TNF-Epithelial_airway\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SERPINB4 CFAP44 CTSV DNAH1	6.86e-05	200	49	4	72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb
ToppCell	mild-immature_Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SPAG1 WDPCP DNAH1	2.35e-04	109	49	3	2f03d6ee8b13424cc6a5bc60ac3461b44dff9d79
ToppCell	LPS-antiTNF-Unknown-Endothelial-Pericyte_2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MKI67 CCDC102B RYR2	4.12e-04	132	49	3	02491930097b75aaeedab9e8200711b0dc610944
Disease	Polynesian Bronchiectasis	SPAG1 DNAAF4 DNAH1	2.71e-05	35	49	3	C4317124
Disease	Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus	SPAG1 DNAAF4 DNAH1	2.71e-05	35	49	3	C4551906
Disease	Kartagener Syndrome	SPAG1 DNAAF4 DNAH1	2.71e-05	35	49	3	C0022521
Disease	Primary ciliary dyskinesia	SPAG1 DNAAF4 DNAH1	2.96e-05	36	49	3	cv:C0008780
Disease	Primary Ciliary Dyskinesia	SPAG1 DNAAF4 DNAH1	6.63e-05	47	49	3	C4551720
Disease	exercise test	ZC3H12C RYR2	5.04e-04	20	49	2	EFO_0004328
Disease	colorectal cancer (is_implicated_in)	SETD2 FAT1 MKI67	1.08e-03	121	49	3	DOID:9256 (is_implicated_in)
Disease	radius bone mineral density	ACTR3B MAP3K1	1.46e-03	34	49	2	EFO_0007933
Disease	sleep measurement	ACTR3B CFAP44 RYR2	1.48e-03	135	49	3	EFO_0004870
Disease	esophagus squamous cell carcinoma (is_implicated_in)	FAT1 MAP3K1	2.56e-03	45	49	2	DOID:3748 (is_implicated_in)
Disease	response to angiotensin-converting enzyme inhibitor, Cough	NIBAN1 ACTR3B	2.67e-03	46	49	2	EFO_0005325, HP_0012735
Disease	hepatocellular carcinoma (implicated_via_orthology)	IQGAP2 CTSV	3.02e-03	49	49	2	DOID:684 (implicated_via_orthology)
Disease	susceptibility to common cold measurement	NIBAN1 ACTR3B	3.66e-03	54	49	2	EFO_0008417
Disease	Hypertrophic Cardiomyopathy	KLF10 RYR2	4.07e-03	57	49	2	C0007194
Disease	Psoriasis	MKI67 ZC3H12C	4.07e-03	57	49	2	C0033860
Disease	Pustulosis of Palms and Soles	MKI67 ZC3H12C	4.07e-03	57	49	2	C0030246
Disease	alcohol use disorder (implicated_via_orthology)	CTSV UTY RYR2	4.19e-03	195	49	3	DOID:1574 (implicated_via_orthology)
Disease	basophil measurement	ELF1 WDPCP	4.50e-03	60	49	2	EFO_0803539

Protein segments in the cluster

Peptide	Gene	Start	Entry
KATCPKYIKWTQREK	ELF1	221	P32519
KETEKWNIKPESKYF	DNPEP	61	Q9ULA0
KSVDWRKKGYVTPVK	CTSV	116	O60911
EFAKYDVDPRKWIKQ	ACTR3B	241	Q9P1U1
RQDKEAWIKDKYVEK	ACAP3	501	Q96P50
IQQRKKEWEELYKSK	CFAP44	1136	Q96MT7
WKVYVKKPLDREKRD	FAT1	2976	Q14517
GDIKDKVTAWKQYRK	ITIH1	111	P19827
KEFAKYDVDPQKWIK	ACTR3C	111	Q9C0K3
EWYRLQEKKMEKDPS	ANKRD49	61	Q8WVL7
KKNESPFWKLYESVK	MKI67	231	P46013
LEKKQKLAESRDYPW	WDPCP	76	O95876
PKEWKKEASKVRQYE	FRMD6	81	Q96NE9
EDPKSQKLKYKWCEV	DNAH1	291	Q9P2D7
PKDFYDKIEAKKWQE	CKAP5	281	Q14008
DDPKLTARKYREWKV	IPCEF1	381	Q8WWN9
KEEEWDPEYTPKSKK	BCLAF1	831	Q9NYF8
YKSDQWKPLNLEEKK	EIF4G1	596	Q04637
PEDKAKYVKERTWRS	ME2	546	P23368
AWKEYQRKAEEQKKI	DNAAF4	161	Q8WXU2
SWKSDFKKYVENRPV	KLF10	51	Q13118
SEEDIWEYKSKRKPK	DCLRE1A	6	Q6PJP8
KEERWKKRYEVVNGK	GCNT1	251	Q02742
KEKEIYRWPIKESLK	RYR2	2766	Q92736
KWKYEELKESKPKNV	CCDC102B	296	Q68D86
VTKKVDYWDKDVRQK	PTCHD3	661	Q3KNS1
PDWEKKVIEYFKEKL	MCMBP	26	Q9BTE3
EWKEKVPEAKRLYGK	KIF13A	761	Q9H1H9
TKAKQPYREDTEWLK	MAP3K1	1231	Q13233
ERYEWNKLKSVKSPV	UTY	1201	O14607
AVNEPKKKKYAKEAW	PPP1R8	326	Q12972
LAPEYQKELWDAKKK	IQGAP2	251	Q13576
QRWRELPDSKKKIYQ	TFAM	86	Q00059
KEEKFWPNKNTYKSI	SERPINB3	196	P29508
NFKKIYWPAAKERVE	SEMA3D	101	O95025
PKKKEYKEWKSQVQS	TP53TG5	121	Q9Y2B4
RKKLEEYNAPWKERV	TRIM61	141	Q5EBN2
WEFEKYQRLLEKKQP	TRIM68	186	Q6AZZ1
EDIKKWKERYVVVKN	NIBAN1	81	Q9BZQ8
RVQKKDPKDWAVQYR	TRO	626	Q12816
DPDKKNWKRKIIAVY	PRSS35	356	Q8N3Z0
KKKTPRDYAEWDKFD	SPAG1	151	Q07617
KEEKFWPNKNTYKSV	SERPINB4	196	P48594
NEPLKKERLKWKSDY	UBTD1	26	Q9HAC8
YRDLQVEKPEWKKFI	ZC3H12B	301	Q5HYM0
WKDLKEVYRIPKKSQ	SETD2	2016	Q9BYW2
TKWKGEVKKRLDSEY	TMEM19	111	Q96HH6
YRDLANEKPEWKKFI	ZC3H12C	356	Q9C0D7
REKDKEKKWIFQICP	ABI3BP	161	Q7Z7G0